Suzie Marshall
Innovation: ISET audience hears what’s on the horizon for CLTI patients
“I am going to give you reasons to be excited about your critical limb practice,” Peter Schneider, MD, professor of vascular and endovascular surgery...
Registry data show EVAR is safe, durable and effective out to...
Endovascular aortic repair (EVAR) is safe, durable and effective, the five-year interim results of the Global Registry for Endovascular Aortic Treatment (the GREAT registry)...
‘Radiation will be a thing of the past’
Discussion during the opening day of the Charing Cross (CX) 2021 Digital Edition emphasized the potential of Philips’ Fiber Optic RealShape (FORS) technology to...
‘More robust’ studies needed to confirm near infrared spectroscopy as valuable...
“The available data suggest that exercise training improves de-oxygenation and re-oxygenation patterns, as measured with near infrared spectroscopy (NIRS), in patients with lower extremity...
FDA grants breakthrough device designation for Zenith fenestrated+ endovascular graft
The Zenith fenestrated+ endovascular graft (ZFEN+) product (Cook Medical) has received breakthrough device designation from the Food and Drug Administration (FDA). This designation is...
Journal of Critical Limb Ischemia set to launch in spring
The CLI Global Society is launching the first peer-reviewed academic journal focusing on interventional techniques pertaining to critical limb ischemia (CLI). The new title, Journal...
Postmarket study of sirolimus-eluting balloon enrolls first patient
MedAlliance has announced enrollment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon Selution SLR for the treatment...
Data show potential of Limflow system to improve outcomes for no-option...
“Deep vein arterialization is safe and technically feasible,” Peter Schneider, MD, a professor in the division vascular and endovascular surgery at the University of...
Walking can relieve leg pain in people with PAD
Exercise can play an important role in treating peripheral arterial disease (PAD), a recent review by Amy Harwood, PhD, from the Centre for Sport and...
HIFLO RCT finds increased wound closure, high-quality healing using mVASC microvascular...
Treatment with the mVASC microvascular tissue graft product (MicroVascular Tissues) results in superior wound closure compared to standard of care alone, the first randomized...
Intravascular lithotripsy ‘superior’ to PTA in acute procedural success out to...
The DISRUPT PAD III randomized controlled trial (RCT) provides the largest level-one evidence for the treatment of heavily calcified femoropopliteal arteries, noted William Gray,...
Latest VOYAGER PAD analysis finds no mortality and improved limb outcomes...
Given the absence of a safety signal in data from the VOYAGER PAD trial, a new analysis examined the potential benefit of drug-coated device...
Janssen applies to FDA for new indication to expand use of...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the Food and Drug...
TCT 2020 late-breaking trials session features new data on drug-coated devices
Findings from a series of late-breaking trials in the endovascular field were delivered recently at TCT Connect (Oct. 14–18), the 32nd annual scientific symposium...
UK study shows early treatment for leg ulcers leads to better...
To deliver clinical and cost benefits, leg ulcer care pathways should be revised to include early assessment and treatment of superficial venous reflux, researchers...
First patient recruited into study on use of bridging stents in...
The first patient has been recruited into a trial investigating the BeGraft peripheral plus stent graft system (Bentley InnoMed) as a dedicated bridging stent in...
‘No signal of increased risk of long-term mortality’ with paclitaxel-coated Luminor...
An ad hoc, two-year analysis of the EffPac study found no signal of increased risk of long-term mortality, nor any adverse events, within two years...
Ascending aorta: Challenges of obtaining data discussed at CX Aortic Vienna
In the ascending aorta session at CX Aortic Vienna, presentations focused on various treatment options, including frozen elephant trunk (FET) and endovascular intervention. The...
Inaugural CX Aortic Vienna to take place online
The inaugural CX Aortic Vienna meeting will be livestreamed Sept. 8–11 to an international, online audience, and will include registrant participation, interaction and polling.
The...
Study finds racial disparities in acute stroke thrombectomy management
A new study has found several racial disparities after mechanical thrombectomy for stroke with respect to post-procedure management and outcomes. Vineeth Thirunavu of Northwestern...
BD acquires Straub Medical
Straub Medical, which manufactures, develops and sells medical devices for the treatment of arterial and venous diseases, has been acquired by Becton, Dickinson and...
Nearly 70% of CX 2020 LIVE global aortic audience finds type...
A global audience tuned into the second session and inaugural aortic offering of CX 2020 LIVE. With registrations now well over 4,000, the pioneering virtual...
CX 2020 LIVE pioneers virtual vascular conference format in COVID-19 era
CX 2020 LIVE came to life online—despite COVID-19—using state-of-the art broadcast technology to bring together more than 1,000 vascular specialists, live, from 95 countries across...
Global vascular community addresses geographic disparity in COVID-19 impact and response
LONDON—Last week, the Charing Cross (CX) Symposium 2020 would have taken place in the U.K. capital. To mark the occasion virtually, experts from across...
Straub Medical announces first patient treated in US with Rotarex S...
Straub Medical, the US direct-sales subsidiary of Swiss outfit Straub Medical AG, has announced the launch and first intervention performed with the Rotarex S...
FDA official delivers government agency’s early reaction to latest contentious meta-analysis...
HOLLYWOOD, Fla.—A Food and Drug Administration (FDA) official delivered a talk which represents the government agency’s earliest public reaction to the latest meta-analysis suggesting...
Medical education requires a reboot in the digital age, argues stent-grafting...
LAS VEGAS—Medical education is confronted by huge opportunities with the coming of what has been termed the fourth industrial revolution—that of the intersection where...
New meta-analysis finds ‘no observed difference’ in mortality between paclitaxel and...
February 2020 brings another paclitaxel device meta-analysis of randomized controlled trials in chronic limb-threatening ischemia (CLTI) patients. Krystal Dinh, BMed, of Westmead Hospital, Sydney,...
Hotly-contested meta-analysis suggests a higher risk of death or amputation at...
A new meta-analysis, just published in the Journal of Vascular and Interventional Radiology (JVIR), suggests significantly reduced amputation-free survival at one year when paclitaxel-coated...
Alucent Biomedical announces FDA approval to proceed with natural vascular scaffolding...
Alucent Biomedical has received US Food and Drug Administration (FDA) approval to proceed with a phase 1 clinical trial to evaluate the safety and...